Nature’s Truth breathes passion into aromatherapy sector through YouTube
RONKONKOMA, N.Y. – Nature's Truth announced Tuesday they will be airing original YouTube videos featuring Nature’s Truth associates. “We want customers to meet the people behind the face of Nature’s Truth, and get to know us – learning firsthand from us the different ways that we use our products daily,” stated Kimberly Vigliante, SVP sales and marketing. “Creating a Nature’s Truth YouTube channel featuring some of our favorite DIY’s helps us connect on a more personal level with consumers to create a close community.”
Nature’s Truth associates who live and breathe aromatherapy, will take viewers on a health and wellness journey to incorporate essential oils into their daily lives. With an increasing number of consumers utilizing social media to gain insight on aromatherapy, Nature’s Truth is engaging their consumers by creating an online community through videos, with relatable content and produced in-house by their very own associates.
“'DIY with Lindsay' is our first series that we are airing, which launched in August, and we have already received extensive requests for more DIY projects and tips from customers,” Vigliante said.
DEA places kratom plant onto schedule I
WASHINGTON – The Drug Enforcement Administration last week announced its intention to place the active materials in the kratom plant into Schedule I of the Controlled Substances Act in order to avoid an imminent hazard to public safety.
“Kratom has been a public health target for almost five years, and its surging growth in use and availability is an unfortunate but real example of the federal government’s unwillingness to use existing authorities to enforce the law," stated Dan Fabricant, Natural Products Association CEO and executive director. "This is a necessary and welcome step, but unless it is followed with real enforcement and penalties for those who are selling it in coffee bars, on the internet and elsewhere, it will be toothless," he said. “Kratom is not an herbal supplement: it is addictive, harmful, and worse, it may be contributing to America’s opiate epidemic. We are eager to work with the authorities and our members to help turn the tide against Kratom and ensure that it is seen as what the DEA says it is, a schedule I illegal narcotic that has no place in health or wellness."
Mitragynine and 7-hydroxymitragynine are found in kratom, which is a tropical tree indigenous to Thailand, Malaysia, Myanmar, and other areas of Southeast Asia. Kratom has been on DEA’s list of drugs and chemicals of concern for several years.
Kratom is abused for its ability to produce opioid-like effects and is often marketed as a legal alternative to controlled substances. In addition, kratom has a high potential for abuse, has no currently accepted medical use in treatment in the United States, and has a lack of accepted safety for use under medical supervision. These three factors constitute a Schedule I controlled substance according to the Controlled Substances Act passed by Congress in 1970.
The FDA has also warned the public not to use any products labeled as containing kratom due to concerns about toxicity and potential health impacts. In addition, FDA has issued and updated two import alerts related to kratom products.
CVS Health introduces latest campaign benefiting Stand Up To Cancer
WOONSOCKET, R.I. – CVS Health on Tuesday launched an in-store fundraising campaign at CVS Pharmacy locations nationwide to benefit Stand Up To Cancer, a program of the Entertainment Industry Foundation, that supports innovative cancer research that gets new therapies to patients quickly to save more lives.
Through Oct. 1, CVS Pharmacy customers can support SU2C by making a $1, $3 or larger donation at the register at 7,900 CVS Pharmacy locations or online at www.CVS.com/SU2C. The in-store fundraising campaign is part of a three-year, $10 million commitment by CVS Health to SU2C.
"With more than 1.6 million Americans diagnosed with cancer each year, we know many of our colleagues, customers and communities have been affected by this terrible disease," stated Helena Foulkes, president, CVS Pharmacy. "As part of our company's purpose of helping people on their path to better health, we're proud to support Stand Up To Cancer as they accelerate research and bring new therapies to patients."
Donations made during the campaign will support SU2C's collaborative cancer research model which helps bring new treatments to patients faster. SU2C's "Dream Teams" bring together scientists from different institutions and across multiple disciplines to work together to translate their research from the laboratory to the patient.
"Because of partners like CVS Health, we're able to make progress in increasing treatment options for patients and making advancements in the fight against cancer," said SU2C co-founder Sue Schwartz. "We're thankful for the support CVS Health has given to us over the past few years by giving its customers an easy way to make a donation and joining us in our mission of making everyone diagnosed with cancer a survivor."
CVS Pharmacy customers can also support SU2C through Oct. 1, when they purchase Nicorette or NicoDerm CQ, which help reduce cravings and withdrawal symptoms associated with quitting smoking. For every box sold at CVS Pharmacy, GSK Consumer Healthcare will donate $1 to Stand Up To Cancer, up to $100,000.
"Teaming up with CVS Pharmacy is a natural fit for GSK Consumer Healthcare, as both companies look to help smokers rid their lives of cigarettes and become smoke-free," said James Masterson, marketing director at GSK Consumer Healthcare. "We are encouraging those interested in quitting to quit for a cause this month."
CVS Health is also a proud supporter of SU2C's fifth biennial televised fundraising special which will air on Friday, Sept. 9. The Stand Up To Cancer telecast raises awareness and funds to support SU2C's translational research that can provide patients with new therapies to save lives now. One hundred percent of public monies pledged during the telecast support SU2C's cancer research programs.